AQP4 and myeloid sarcoma: We compared longitudinal brain atrophy in patients with AQP4 + NMOSD to longitudinal brain atrophy in patients with MS and showed that brain atrophy silently progressed in patients with AQP4 + NMOSD, even in clinically inactive patients10.